Wall Street surges on signs of economic rebound
Wall Street jumped in a broad rally on Wednesday, closing ground on all-time highs as signs of recovery from mandated economic shutdowns helped investors look...
Snap removes Trump account from curated promotional section
Snap Inc said it would no longer promote U.S. President Donald Trump’s account in Snapchat’s Discover section, saying his inflammatory comments last week made the...
Oil hovers below $40 as doubts emerge over next step on OPEC cuts
Oil pulled back slightly on Wednesday after briefly jumping above $40 a barrel, the highest since March, retreating as doubts emerged about the timing and...
Citigroup chief compliance officer Mark Carawan retires
Citigroup Inc said on Wednesday its chief compliance officer Mark Carawan is retiring after eight years at the firm, effective June 8....
Heads of U.S. automakers, other Michigan companies condemn racism, injustice
Top executives of the Detroit Three automakers and other major Michigan employers on Wednesday condemned racism and injustice in the United States following the death...
Wall Street rises on Boeing, economic recovery hopes
A jump in Boeing shares led Wall Street higher on Wednesday, with investors hopeful of a rebound from a coronavirus-led economic slump amid continuing social...
Global smartphone shipments to fall 12% this year on virus woes: IDC
Global smartphone shipments will fall nearly 12% to 1.2 billion units in 2020, market research firm IDC said on Wednesday, citing lower consumer spending due...
U.S. labor market stabilizing as layoffs abate
U.S. private payrolls fell less than expected in May, suggesting layoffs were abating as businesses reopen, though the overall economy’s recovery from the COVID-19 pandemic...
TUI strikes compensation deal with Boeing, delays 737 MAX deliveries
Europe’s biggest travel company, TUI Group , said it has struck a deal with Boeing for compensation and deferred deliveries of the grounded 737 MAX...
Gilead’s remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
Gilead Sciences Inc’s potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug...